Floatz logo

Remegal

Epilepsy

ValexfarmPhase 3Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
73/ 100

Competitive context

77 Active assets in the Epilepsy cohort.

Asset / SponsorPhaseRating
Topamax
SK Life Science, Inc.
Phase 4BBB
Keppra
Beijing Tiantan Hospital
Phase 4BBB
Topamax
Université de Sherbrooke
Phase 4BBB
LAMOTRIGINE
Assiut University
Phase 4BBB
Lacosamide
Second Affiliated Hospital of Guangzhou Medical University
Phase 4BBB

View all 50 →

Same molecule, other indications

Remegal is also rated in:

benign partial epilepsy of infancy with complex partial seizuresDormant
BB
Indicative ·
64 / 100
View asset →
simple partial epilepsyDormant
NR
Indicative ·
/ 100
View asset →
focal epilepsyDormant
NR
Indicative ·
/ 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →